Search results
Results from the WOW.Com Content Network
Medlife was an Indian online platform, which provided pharmacy, diagnostics, and e-consultation in India. It was founded in 2014 by Prashant Singh and Tushar Kumar. The company had a central laboratory based in Bangalore and operated in 29 states.
Phentermine and topiramate was developed by Vivus, a California pharmaceutical company. In December 2009, Vivus, Inc. submitted a new drug application (NDA) to the FDA and on 1 March 2010, Vivus, Inc. announced that the FDA accepted the NDA for review.
PharmEasy competes with other e-pharmacy companies including Netmeds (which was acquired by Reliance Industries), 1mg (acquired by Tata Group), Apollo 24x7 and Amazon Pharmacy. [11] The Ken questioned the company's positioning as a unified healthtech player and referred to the company's story as "more confusing than convincing".
Weight loss can be a challenge, even for those who eat healthily and exercise regularly. But injectable type 2 diabetes medications — also known as GLP-1 and GIP injections — are changing the ...
Phentermine is an norepinephrine and dopamine releasing agent (NDRA) and produces stimulant, rewarding, and appetite suppressant effects. [8] [9] [10] Chemically, it is a substituted amphetamine. [11] Phentermine was approved for medical use in the United States in 1959. [3] It is available as a generic medication. [3]
The loss of independent pharmacies in particular has created pharmacy deserts where access to prescriptions is difficult. Between 2013 and 2022, about 10% of independent pharmacies in rural areas ...
It’s important to point out that the study is awaiting peer review, which is when the medical community evaluates and analyzes a study; that is considered the gold standard in research.
Tata 1mg, previously 1mg, [3] is a healthcare platform based in Gurugram, India. It provides services, including e-pharmacy , diagnostics , e-consultation , and health content. It was founded in April 2015 by Prashant Tandon, Gaurav Agarwal, and Vikas Chauhan.